Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 1,587,000 | 1,801,000 | 2,151,000 | 1,121,000 | 2,785,000 |
Marketable Securities | 20,325,000 | 20,993,000 | 8,199,000 | 8,525,000 | 6,302,000 |
Receivables | 10,012,000 | 9,128,000 | 9,881,000 | 6,772,000 | 9,439,000 |
Inventories | 9,295,000 | 8,564,000 | 8,423,000 | 7,068,000 | 8,222,000 |
Income taxes - deferred | N/A | 3,426,000 | 3,346,000 | 2,736,000 | N/A |
Other current assets | 6,520,000 | 2,512,000 | 2,738,000 | 6,581,000 | 6,711,000 |
TOTAL | $47,739,000 | $46,424,000 | $34,738,000 | $32,803,000 | $33,459,000 |
Non-Current Assets | |||||
PPE Net | 14,403,000 | 14,113,000 | 14,040,000 | 12,969,000 | 13,701,000 |
Investments And Advances | 19,008,000 | 18,720,000 | 18,220,000 | 20,147,000 | 18,722,000 |
Intangibles | 90,829,000 | 91,990,000 | 92,966,000 | 82,138,000 | 97,660,000 |
Other Non-Current Assets | 7,004,000 | 6,687,000 | 6,373,000 | 19,537,000 | 6,904,000 |
TOTAL | $131,244,000 | $131,510,000 | $131,599,000 | $134,791,000 | $136,987,000 |
Total Assets | $178,983,000 | $177,934,000 | $166,336,000 | $167,594,000 | $170,446,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 13,363,000 | 13,084,000 | 16,007,000 | 16,195,000 | 16,617,000 |
Accounts payable and accrued liabilities | 4,141,000 | 3,872,000 | 3,972,000 | 3,887,000 | 3,942,000 |
Accrued Expenses | 2,425,000 | 2,042,000 | 2,246,000 | 2,390,000 | 2,369,000 |
Other current liabilities | 10,683,000 | 10,168,000 | 10,515,000 | 9,334,000 | 10,160,000 |
TOTAL | $34,154,000 | $32,723,000 | $33,890,000 | $37,304,000 | $36,974,000 |
Non-Current Liabilities | |||||
Long Term Debt | 49,785,000 | 50,529,000 | 36,281,000 | 35,955,000 | 36,044,000 |
Other Non-Current Liabilities | 25,000,000 | 24,702,000 | 25,550,000 | 25,228,000 | 25,305,000 |
TOTAL | $79,335,000 | $80,648,000 | $67,108,000 | $66,844,000 | $68,077,000 |
Total Liabilities | $113,487,000 | $113,370,000 | $100,998,000 | $104,148,000 | $105,051,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 5,558,396 | 5,556,880 | 5,554,834 | 5,547,639 | 5,534,122 |
Common Shares | 470,000 | 470,000 | 470,000 | 468,000 | 468,000 |
Retained earnings | 100,284,000 | 100,203,000 | 101,000,000 | 97,670,000 | 100,113,000 |
Other shareholders' equity | -12,440,000 | -13,017,000 | -12,802,000 | -11,318,000 | -11,489,000 |
TOTAL | $65,495,000 | $64,564,000 | $65,338,000 | $63,447,000 | $65,396,000 |
Total Liabilities And Equity | $178,982,000 | $177,934,000 | $166,336,000 | $167,595,000 | $170,447,000 |